Comparative Efficacy of .sup.177Lu and .sup.90Y for Anti-CD20 Pretargeted Radioimmunotherapy in Muri...
Comparative Efficacy of .sup.177Lu and .sup.90Y for Anti-CD20 Pretargeted Radioimmunotherapy in Murine Lymphoma Xenograft Models
About this item
Full title
Author / Creator
Publisher
Public Library of Science
Journal title
Language
English
Formats
Publication information
Publisher
Public Library of Science
Subjects
More information
Scope and Contents
Contents
Pretargeted radioimmunotherapy (PRIT) is a multi-step method of selectively delivering high doses of radiotherapy to tumor cells while minimizing exposure to surrounding tissues. Yttrium-90 (.sup.90 Y) and lutetium-177 (.sup.177 Lu) are two of the most promising beta-particle emitting radionuclides used for radioimmunotherapy, which despite having...
Alternative Titles
Full title
Comparative Efficacy of .sup.177Lu and .sup.90Y for Anti-CD20 Pretargeted Radioimmunotherapy in Murine Lymphoma Xenograft Models
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_gale_infotracmisc_A423951208
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_gale_infotracmisc_A423951208
Other Identifiers
ISSN
1932-6203
E-ISSN
1932-6203
DOI
10.1371/journal.pone.0120561
